Problems with Using Women's Cancer Screening Rates to Measure Performance
Paul A. Heineken, MD, Cheryl Wenell, RNP, MS, Karla Kerlikowske, MD, and Louise C. Walter, MD
Dr. Heineken is the associate chief of staff of ambulatory care, Ms. Wenell is the coordinator of the Women Veterans Program, Dr. Kerlikowske is the director of the Women's Clinic, and Dr. Walter is a staff physician, all at the San Francisco VA Medical Center, San Francisco, CA. In addition, Dr. Heineken is a clinical professor in the School of Medicine, Ms. Wenell is an associate clinical professor in the School of Nursing, Dr. Kerlikowske is a professor in residence in the departments of medicine and epidemiology and biostatistics in the School of Medicine, and Dr. Walter is an associate professor in the division of geriatrics and the codirector of the Geriatrics Research Program in the School of Medicine, all at the University of California, San Francisco.
When a VA audit determined that the San Francisco VA Medical Center had underperformed with regard to breast and cervical cancer screening, these authors reviewed the medical charts of patients who were counted as screening failures. Their findings point to flaws with the VA’s auditing process and its use of women’s cancer screening rates as performance measures.
Recommended Reading
Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment Publish date: September 30, 2022 -
Genetic tests create treatment opportunities and confusion for breast cancer patients Publish date: September 22, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
-
Publish date: September 22, 2021
-
Publish date: September 3, 2021
-
Publish date: May 20, 2021
-
-
Multimedia
-
Data underscore the importance of lifestyle interventions in breast cancer patients Publish date: December 17, 2018 -
Publish date: December 14, 2018
-
Extending Therapy for Breast Cancer Publish date: September 3, 2014
Conference Coverage
-
Most women with breast cancer elude serious COVID-19 vaccine side effects Publish date: December 16, 2022 -
Exciting advances in HR-positive breast cancer: Top five picks from SABCS Publish date: December 16, 2022 -
Whole breast radiation for breast cancer shown to be safe and effective Publish date: December 1, 2022 -
Findings may be practice changing for early breast cancer patients Publish date: October 31, 2022 -
What is known about sexual dysfunction after breast cancer? Publish date: October 5, 2022 -
A farewell to arms? Drug approvals based on single-arm trials can be flawed Publish date: September 19, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Select patients with breast cancer may skip RT after lumpectomy Publish date: July 12, 2022 -
Publish date: June 28, 2022
-
Survival for elderly breast cancer patients 25% after 4 years Publish date: June 20, 2022
Factors related to breast cancer surgery choices
